214 fundamentals
An in-depth look to ANEBULO PHARMAC. DL-,001 operating, investing, and financing activities
214 free cash flow for Q3 24 is -1.39 M EUR. For 2023, 214 free cash flow was -8.88 M EUR and operating cash flow was -8.88 M EUR.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM